miR-106a levels in (A) Circulation and (B) tissue of Breast Cancer Patients and healthy controls.

miRNAs that are Dysregulated in cancer correlated with cancer differentiation.

Xiaobing Wu (190298)
Xuehu Xu (710871)
Shuling Li (710872)
Shangbiao Wu (710873)
Rong Chen (29176)
Qingping Jiang (87938)
Haibo Liu (171264)
Yan Sun (22436)
Yong Li (15029)
Yuandong Xu (710874)

March 2015

(A) Compared with normal tissues, a total of 93 miRNAs that were significantly dysregulated were ...

Differential Expression of MicroRNAs in Breast Cancers from Four Different Ethnicities

Pollard, J
Burns, PA
Hughes, TA
Ho-Yen, C
Jones, JL
Mukherjee, G
Omoniyi-Esan, GO
Titloye, NA
Speirs, V
Shaaban, AM

May 2018

Breast cancer outcomes vary across different ethnic groups. MicroRNAs (miRs) are small non-coding RN...

miR-100 inhibits tumorigenesis and is downregulated in human breast cancer.

Dahu Chen (528122)
Yutong Sun (244487)
Yuan Yuan (25702)
Zhenbo Han (528123)
Peijing Zhang (236461)
Jinsong Zhang (42064)
M. James You (528124)
Julie Teruya-Feldstein (258616)
Min Wang (21070)
Sumeet Gupta (184218)
Mien-Chie Hung (102628)
Han Liang (8068)
Li Ma (46633)

February 2014

(A) miR-100 expression levels in four subtypes of human breast tumors and paired normal breast ti...

miR-191 levels in (A) Circulation and (B) tissue of Breast Cancer Patients and healthy controls.

Peadar S. Waters (114309)
Roisin M. Dwyer (114342)
Cathy Brougham (535206)
Claire L. Glynn (535207)
Deirdre Wall (114317)
Peter Hyland (535208)
Maria Duignan (535209)
Mark McLoughlin (535210)
John Newell (114330)
Michael J. Kerin (114334)

March 2014

Levels in breast cancer patients were further subdivided based on epithelial subtype of the disea...

miR-138 levels in (A) Circulation and (B) tissue of Breast Cancer Patients and healthy controls.

Peadar S. Waters (114309)
Roisin M. Dwyer (114342)
Cathy Brougham (535206)
Claire L. Glynn (535207)
Deirdre Wall (114317)
Peter Hyland (535208)
Maria Duignan (535209)
Mark McLoughlin (535210)
John Newell (114330)
Michael J. Kerin (114334)

March 2014

Levels in breast cancer patients were further subdivided based on epithelial subtype of the disea...

Impact of tumour epithelial subtype on circulating micrornas in breast cancer patients

Waters, Peadar S.
Dwyer, Róisín M.
Brougham, Cathy
Glynn, Claire L.
Wall, Deirdre
Hyland, Peter
Duignan, Maria
McLoughlin, Mark
Newell, John
Kerin, Michael J.

March 2014

While a range of miRNAs have been shown to be dysregulated in the circulation of patients with breas...

Impact of tumour epithelial subtype on circulating microRNAs in breast cancer patients.

Peadar S Waters
Roisin M Dwyer
Cathy Brougham
Claire L Glynn
Deirdre Wall
Peter Hyland
Maria Duignan
Mark McLoughlin
John Newell
Michael J Kerin

While a range of miRNAs have been shown to be dysregulated in the circulation of patients with breas...

Impact of Tumour Epithelial Subtype on Circulating microRNAs in Breast Cancer Patients

Peadar S. Waters
Roisin M. Dwyer
Cathy Brougham
Claire L. Glynn
Deirdre Wall
Peter Hyl
Maria Duignan
Mark Mcloughlin
John Newell
Michael J. Kerin

August 2016

While a range of miRNAs have been shown to be dysregulated in the circulation of patients with breas...

Impact of Tumour Epithelial Subtype on Circulating MicroRNAs in Breast Cancer Patients

Waters, Peadar S.
Dwyer, Roisin M.
Brougham, Cathy
Glynn, Claire L.
Wall, Deidre
Hyland, Peter
Duignan, Maria
McLoughlin, Mark
Newell, John
Kerin, Michael J.

March 2014

While a range of miRNAs have been shown to be dysregulated in the circulation of patients with breas...

Levels of circulating miRNAs in breast cancer patients and healthy controls.

Hongjiang Wang (171043)
Guang Tan (171049)
Lei Dong (165252)
Lei Cheng (171055)
Kejun Li (171059)
Zhongyu Wang (171066)
Haifeng Luo (171072)

April 2012

Relative levels of circulating miR-10b, miR-34a, miR-125b and miR-155 were measured in healthy in...

Down-regulation of miR-101 in breast cancer tissues.

Rui Wang (52434)
Hong-Bin Wang (128886)
Chan Juan Hao (128887)
Yi Cui (128888)
Xiao-Chen Han (128890)
Yi Hu (58993)
Fei-Feng Li (128893)
Hong-Fei Xia (128895)
Xu Ma (45624)

October 2012

We pooled two patients' cancer tissues as a sample. The expression level of miR-101 in ind...

Clinical characteristics of breast cancer patients at the beginning of the study and their association with serum miR-21, miR-10b, and miR-19a levels.

Simone Anfossi (507020)
Antonio Giordano (55096)
Hui Gao (169623)
Evan N. Cohen (507021)
Sanda Tin (507022)
Qiong Wu (84327)
Raul J. Garza (507023)
Bisrat G. Debeb (243740)
Ricardo H. Alvarez (507024)
Vicente Valero (507025)
Gabriel N. Hortobagyi (209944)
George A. Calin (150225)
Naoto T. Ueno (450641)
Wendy A. Woodward (243750)
James M. Reuben (170012)

January 2014

Clinical characteristics of breast cancer patients at the beginning of the study and their associ...

The expression level of six specific miRNAs in tissue specimens from TNBC and other subtypes of breast cancer, benign breast cancer and controls.

Seema Thakur (2873297)
Rajesh K. Grover (2873300)
Sanjay Gupta (106066)
Ajay K. Yadav (2873294)
Bhudev C. Das (434799)

July 2016

(A) The expression level of miR-21, miR-221, miR-210, miR-195, miR-145 and Let-7a in total breast...

MiRNA levels in benign and malignant breast tissue.

Katarina Cuk (475833)
Manuela Zucknick (398988)
Dharanija Madhavan (475834)
Sarah Schott (146543)
Michael Golatta (475835)
Jörg Heil (475836)
Frederik Marmé (475837)
Andrey Turchinovich (475838)
Peter Sinn (386925)
Christof Sohn (146476)
Hans Junkermann (475839)
Andreas Schneeweiss (146474)
Barbara Burwinkel (146479)

October 2013

Levels of miR-127-3p, miR-376a and miR-652 are decreased in malignant primary breast cancer when ...

Comparison of miRs expression levels in normal and tumor mammary tissues among triple negative and non triple negative mammary tumors.

Imen Medimegh (698209)
Ines Omrane (698210)
Maud Privat (596015)
Nancy Uhrhummer (698211)
Hajer Ayari (85739)
Fadoua Belaiba (698212)
Farhat Benayed (698213)
Khaled Benromdhan (698214)
Sylvie Mader (63328)
Ives-Jean Bignon (698215)
Amel Benammar Elgaaied (490361)

November 2014

Blot letters indicate p Value <0.01, SD: standard deviation.Comparison of miRs expr...

miRNAs that are Dysregulated in cancer correlated with cancer differentiation.

Xiaobing Wu (190298)
Xuehu Xu (710871)
Shuling Li (710872)
Shangbiao Wu (710873)
Rong Chen (29176)
Qingping Jiang (87938)
Haibo Liu (171264)
Yan Sun (22436)
Yong Li (15029)
Yuandong Xu (710874)

March 2015

(A) Compared with normal tissues, a total of 93 miRNAs that were significantly dysregulated were ...

Differential Expression of MicroRNAs in Breast Cancers from Four Different Ethnicities

Pollard, J
Burns, PA
Hughes, TA
Ho-Yen, C
Jones, JL
Mukherjee, G
Omoniyi-Esan, GO
Titloye, NA
Speirs, V
Shaaban, AM

May 2018

Breast cancer outcomes vary across different ethnic groups. MicroRNAs (miRs) are small non-coding RN...

miR-100 inhibits tumorigenesis and is downregulated in human breast cancer.

Dahu Chen (528122)
Yutong Sun (244487)
Yuan Yuan (25702)
Zhenbo Han (528123)
Peijing Zhang (236461)
Jinsong Zhang (42064)
M. James You (528124)
Julie Teruya-Feldstein (258616)
Min Wang (21070)
Sumeet Gupta (184218)
Mien-Chie Hung (102628)
Han Liang (8068)
Li Ma (46633)

February 2014

(A) miR-100 expression levels in four subtypes of human breast tumors and paired normal breast ti...

miR-191 levels in (A) Circulation and (B) tissue of Breast Cancer Patients and healthy controls.

Peadar S. Waters (114309)
Roisin M. Dwyer (114342)
Cathy Brougham (535206)
Claire L. Glynn (535207)
Deirdre Wall (114317)
Peter Hyland (535208)
Maria Duignan (535209)
Mark McLoughlin (535210)
John Newell (114330)
Michael J. Kerin (114334)

March 2014

Levels in breast cancer patients were further subdivided based on epithelial subtype of the disea...

miR-138 levels in (A) Circulation and (B) tissue of Breast Cancer Patients and healthy controls.

Peadar S. Waters (114309)
Roisin M. Dwyer (114342)
Cathy Brougham (535206)
Claire L. Glynn (535207)
Deirdre Wall (114317)
Peter Hyland (535208)
Maria Duignan (535209)
Mark McLoughlin (535210)
John Newell (114330)
Michael J. Kerin (114334)

March 2014

Levels in breast cancer patients were further subdivided based on epithelial subtype of the disea...

Impact of tumour epithelial subtype on circulating micrornas in breast cancer patients

Waters, Peadar S.
Dwyer, Róisín M.
Brougham, Cathy
Glynn, Claire L.
Wall, Deirdre
Hyland, Peter
Duignan, Maria
McLoughlin, Mark
Newell, John
Kerin, Michael J.

March 2014

While a range of miRNAs have been shown to be dysregulated in the circulation of patients with breas...

Impact of tumour epithelial subtype on circulating microRNAs in breast cancer patients.

Peadar S Waters
Roisin M Dwyer
Cathy Brougham
Claire L Glynn
Deirdre Wall
Peter Hyland
Maria Duignan
Mark McLoughlin
John Newell
Michael J Kerin

While a range of miRNAs have been shown to be dysregulated in the circulation of patients with breas...

Impact of Tumour Epithelial Subtype on Circulating microRNAs in Breast Cancer Patients

Peadar S. Waters
Roisin M. Dwyer
Cathy Brougham
Claire L. Glynn
Deirdre Wall
Peter Hyl
Maria Duignan
Mark Mcloughlin
John Newell
Michael J. Kerin

August 2016

While a range of miRNAs have been shown to be dysregulated in the circulation of patients with breas...

Impact of Tumour Epithelial Subtype on Circulating MicroRNAs in Breast Cancer Patients

Waters, Peadar S.
Dwyer, Roisin M.
Brougham, Cathy
Glynn, Claire L.
Wall, Deidre
Hyland, Peter
Duignan, Maria
McLoughlin, Mark
Newell, John
Kerin, Michael J.

March 2014

While a range of miRNAs have been shown to be dysregulated in the circulation of patients with breas...

Levels of circulating miRNAs in breast cancer patients and healthy controls.

Hongjiang Wang (171043)
Guang Tan (171049)
Lei Dong (165252)
Lei Cheng (171055)
Kejun Li (171059)
Zhongyu Wang (171066)
Haifeng Luo (171072)

April 2012

Relative levels of circulating miR-10b, miR-34a, miR-125b and miR-155 were measured in healthy in...

Down-regulation of miR-101 in breast cancer tissues.

Rui Wang (52434)
Hong-Bin Wang (128886)
Chan Juan Hao (128887)
Yi Cui (128888)
Xiao-Chen Han (128890)
Yi Hu (58993)
Fei-Feng Li (128893)
Hong-Fei Xia (128895)
Xu Ma (45624)

October 2012

We pooled two patients' cancer tissues as a sample. The expression level of miR-101 in ind...

Clinical characteristics of breast cancer patients at the beginning of the study and their association with serum miR-21, miR-10b, and miR-19a levels.

Simone Anfossi (507020)
Antonio Giordano (55096)
Hui Gao (169623)
Evan N. Cohen (507021)
Sanda Tin (507022)
Qiong Wu (84327)
Raul J. Garza (507023)
Bisrat G. Debeb (243740)
Ricardo H. Alvarez (507024)
Vicente Valero (507025)
Gabriel N. Hortobagyi (209944)
George A. Calin (150225)
Naoto T. Ueno (450641)
Wendy A. Woodward (243750)
James M. Reuben (170012)

January 2014

Clinical characteristics of breast cancer patients at the beginning of the study and their associ...

The expression level of six specific miRNAs in tissue specimens from TNBC and other subtypes of breast cancer, benign breast cancer and controls.

Seema Thakur (2873297)
Rajesh K. Grover (2873300)
Sanjay Gupta (106066)
Ajay K. Yadav (2873294)
Bhudev C. Das (434799)

July 2016

(A) The expression level of miR-21, miR-221, miR-210, miR-195, miR-145 and Let-7a in total breast...

MiRNA levels in benign and malignant breast tissue.

Katarina Cuk (475833)
Manuela Zucknick (398988)
Dharanija Madhavan (475834)
Sarah Schott (146543)
Michael Golatta (475835)
Jörg Heil (475836)
Frederik Marmé (475837)
Andrey Turchinovich (475838)
Peter Sinn (386925)
Christof Sohn (146476)
Hans Junkermann (475839)
Andreas Schneeweiss (146474)
Barbara Burwinkel (146479)

October 2013

Levels of miR-127-3p, miR-376a and miR-652 are decreased in malignant primary breast cancer when ...

Comparison of miRs expression levels in normal and tumor mammary tissues among triple negative and non triple negative mammary tumors.

Imen Medimegh (698209)
Ines Omrane (698210)
Maud Privat (596015)
Nancy Uhrhummer (698211)
Hajer Ayari (85739)
Fadoua Belaiba (698212)
Farhat Benayed (698213)
Khaled Benromdhan (698214)
Sylvie Mader (63328)
Ives-Jean Bignon (698215)
Amel Benammar Elgaaied (490361)

November 2014

Blot letters indicate p Value <0.01, SD: standard deviation.Comparison of miRs expr...

miRNAs that are Dysregulated in cancer correlated with cancer differentiation.

Xiaobing Wu (190298)
Xuehu Xu (710871)
Shuling Li (710872)
Shangbiao Wu (710873)
Rong Chen (29176)
Qingping Jiang (87938)
Haibo Liu (171264)
Yan Sun (22436)
Yong Li (15029)
Yuandong Xu (710874)

March 2015

(A) Compared with normal tissues, a total of 93 miRNAs that were significantly dysregulated were ...

Differential Expression of MicroRNAs in Breast Cancers from Four Different Ethnicities

Pollard, J
Burns, PA
Hughes, TA
Ho-Yen, C
Jones, JL
Mukherjee, G
Omoniyi-Esan, GO
Titloye, NA
Speirs, V
Shaaban, AM

May 2018

Breast cancer outcomes vary across different ethnic groups. MicroRNAs (miRs) are small non-coding RN...

miR-100 inhibits tumorigenesis and is downregulated in human breast cancer.

Dahu Chen (528122)
Yutong Sun (244487)
Yuan Yuan (25702)
Zhenbo Han (528123)
Peijing Zhang (236461)
Jinsong Zhang (42064)
M. James You (528124)
Julie Teruya-Feldstein (258616)
Min Wang (21070)
Sumeet Gupta (184218)
Mien-Chie Hung (102628)
Han Liang (8068)
Li Ma (46633)

February 2014

(A) miR-100 expression levels in four subtypes of human breast tumors and paired normal breast ti...

miR-106a levels in (A) Circulation and (B) tissue of Breast Cancer Patients and healthy controls.

Abstract

Extracted data

miR-106a levels in (A) Circulation and (B) tissue of Breast Cancer Patients and healthy controls.

Abstract

Extracted data

Related items

Related items